Science Explorer Back to mapMap
Discussion
Nonprofit · Beaverton · United States

Testicular Cancer Commons

Research works
11
▼ 9% vs 2018-21
Citations
56
5.2 per fractional work
Top-10% rate
13.0%
all institutions 10.0%
Open access
40%
world 40%
International
60%
world 18%

Not ranked overall: Testicular Cancer Commons is under the volume floor below which a citation excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does Testicular Cancer Commons work in?

In all years, 89% of research at Testicular Cancer Commons is in Health Sciences, 6% in Life Sciences. Its largest fields are Medicine (89%), Biochemistry, Genetics and Molecular Biology (6%), Arts and Humanities (2%). It does 2.3× the world's share of Health Sciences.

Health Sciences: 10 fractional works · 89.4% of its workMedicine: 10 fractional works · 88.5% of its workSurgery: 3 fractional works · 31.1% of its workPulmonary and Respiratory Medicine: 2 fractional works · 17.5% of its workReproductive Medicine: 1 fractional works · 11.0% of its workPublic Health, Environmental and Occupational Health: 1 fractional works · 9.6% of its workRheumatology: 0 fractional works · 4.5% of its workRadiology, Nuclear Medicine and Imaging: 0 fractional works · 3.8% of its workNeurology: 0 fractional works · 3.1% of its workOncology: 0 fractional works · 2.5% of its workGenetics: 0 fractional works · 1.4% of its workHematology: 0 fractional works · 1.0% of its workInternal Medicine: 0 fractional works · 1.0% of its workPediatrics, Perinatology and Child Health: 0 fractional works · 1.0% of its workEmergency Medicine: 0 fractional works · 0.5% of its workPathology and Forensic Medicine: 0 fractional works · 0.2% of its workHealth Professions: 0 fractional works · 0.9% of its workGeneral Health Professions: 0 fractional works · 0.9% of its workLife Sciences: 1 fractional works · 5.8% of its workBiochemistry, Genetics and Molecular Biology: 1 fractional works · 5.8% of its workMolecular Biology: 1 fractional works · 5.3% of its workCancer Research: 0 fractional works · 0.6% of its workSocial Sciences: 1 fractional works · 4.7% of its workArts and Humanities: 0 fractional works · 1.6% of its workVisual Arts and Performing Arts: 0 fractional works · 1.6% of its workPsychology: 0 fractional works · 1.6% of its workSocial Psychology: 0 fractional works · 1.6% of its workSocial Sciences: 0 fractional works · 1.6% of its workGender Studies: 0 fractional works · 1.6% of its workALL ITS WORKTesticular CancerCommons11fractional works, all years
Life Sciences6%Health Sciences89%Social Sciences5%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 3 domains and 6 fields, with their numbers
    1. Medicine1088.5%
    2. Health Professions00.9%
    1. Biochemistry, Genetics and Molecular Biology15.8%
    1. Arts and Humanities01.6%
    2. Psychology01.6%
    3. Social Sciences01.6%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Biochemistry, Genetics and Molecular Biology: 1.53× its world share, 0 worksBiochemistry, Geneti…Health Professions: 0.79× its world share, 0 worksHealth ProfessionsMedicine: 4.11× its world share, 4 worksMedicineArts and Humanities: 1.23× its world share, 0 worksArts and HumanitiesPsychology: 1.17× its world share, 0 worksPsychologySocial Sciences: 0.28× its world share, 0 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Medicine, 4.1×. Every wedge is a field page.

All 6 fields, with their numbers
  1. Medicine4.11×4 works
  2. Biochemistry, Genetics and Molecular Biology1.53×0 works
  3. Arts and Humanities1.23×0 works
  4. Psychology1.17×0 works
  5. Health Professions0.79×0 works
  6. Social Sciences0.28×0 works

What are the most cited papers from Testicular Cancer Commons?

The most cited paper from Testicular Cancer Commons is "Developing a Highly Specific Biomarker for Germ Cell Malignancies: Plasma miR371 Expression Across the Germ Cell Malignancy Spectrum" (Lucia Nappi et al., 2019), with 127 citations. Next come "Integrated Expression of Circulating miR375 and miR371 to Identify Teratoma and Active Germ Cell Malignancy Components in Malignant Germ Cell Tumors" (67) and "Management of Germ Cell Tumors During the Outbreak of the Novel Coronavirus Disease-19 Pandemic: A Survey of International Expertise Centers" (38).

Most cited papers
#PaperReleasedCitations
1 Developing a Highly Specific Biomarker for Germ Cell Malignancies: Plasma miR371 Expression Across the Germ Cell Malignancy Spectrum Lucia Nappi et al. · Journal of Clinical Oncology Open access 25 Sep 2019 127
2 Integrated Expression of Circulating miR375 and miR371 to Identify Teratoma and Active Germ Cell Malignancy Components in Malignant Germ Cell Tumors Lucia Nappi, Marisa Thi, Nabil Adra et al. · European Urology Open access 4 Nov 2020 67
3 Management of Germ Cell Tumors During the Outbreak of the Novel Coronavirus Disease-19 Pandemic: A Survey of International Expertise Centers Lucia Nappi et al. · The Oncologist Open access 31 Jul 2020 38
4 MicroRNAs as Biomarkers for Germ Cell Tumors Lucia Nappi, Craig R. Nichols · Urologic Clinics of North America 29 May 2019 25
5 The Connection Between Testicular Cancer, Minority Males, and Planned Parenthood Wesley B. Adams, Michael J. Rovito, Mike Craycraft · American Journal of Men s Health Open access 16 Jul 2018 10
All 31 most cited papers, with filters and sorting

Which research topics does Testicular Cancer Commons publish most on?

By volume in 2022-now: Testicular diseases and treatments, Sarcoma Diagnosis and Treatment, Radiomics and Machine Learning in Medical Imaging and Neuroblastoma Research and Treatments.

  1. 1 Testicular diseases and treatments Surgery 1 works
  2. 2 Sarcoma Diagnosis and Treatment Pulmonary and Respiratory Medicine 1 works
  3. 3 Radiomics and Machine Learning in Medical Imaging Radiology, Nuclear Medicine and Imaging 0 works
  4. 4 Neuroblastoma Research and Treatments Neurology 0 works
  5. 5 Ovarian cancer diagnosis and treatment Reproductive Medicine 0 works
  6. 6 Protein Degradation and Inhibitors Molecular Biology 0 works
  7. 7 Urologic and reproductive health conditions Rheumatology 0 works
  8. 8 Media, Gender, and Advertising Gender Studies 0 works
  9. 9 Humor Studies and Applications Social Psychology 0 works
  10. 10 Comics and Graphic Narratives Visual Arts and Performing Arts 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available40.4%not open59.6%

World: 40% of research is openly available.

with international co-authors60.0%domestic only40.0%

World: 18% is written across borders.

How has Testicular Cancer Commons's research output changed?

Output in 2022-2025 was 9% lower than in 2018-2021.

still counting201520202025
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Testicular Cancer Commons as a percentage of every work published that year, 0.0000024% in 2024.

still counting0.000020%0.000040%0.000060%Testicular Cancer Commons0.000031% in 20252020

Fractional works of Testicular Cancer Commons over all fractional works that year. How the balance of science has shifted.

Other research institutions in Beaverton

All research institutions in Beaverton

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Testicular Cancer Commons. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.